BFEC
BSTC

Benjamin F. Edwards & Company’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-206
Closed -$13K – 1803
2020
Q2 		$13K Sell
206
-460
-69% -$26.6K ﹤0.01% 1231
2020
Q1 		$38K Buy
666
+320
+92% +$18.2K ﹤0.01% 917
2019
Q4 		$20K Buy
+346
New +$18.3K ﹤0.01% 1244

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Benjamin F. Edwards & Company's BSTC Position: Q3 2020 in Review

Benjamin F. Edwards & Company sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 206 shares — an estimated $13K sold.

Benjamin F. Edwards & Company first reported a position in BSTC in Q4 2019 and held it in 3 quarters. The position peaked at $38K in Q1 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Benjamin F. Edwards & Company reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 206 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $13K.
  • Benjamin F. Edwards & Company first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 3 quarters.
  • Benjamin F. Edwards & Company's BioSpecifics Technologies Corp. position peaked at $38K in Q1 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2020, filed 13 Nov 2020.